EIF4G2 anticorps (C-Term)

N° du produit ABIN2855138

Détail du produit anti-EIF4G2 anticorps

Antigène: EIF4G2 (Eukaryotic Translation Initiation Factor 4 gamma 2 (EIF4G2))

Épitope: C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EIF4G2 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Réactivité croisée: Humain, Souris

Attributs du produit: Rabbit Polyclonal antibody to DAP5 (eukaryotic translation initiation factor 4 gamma, 2)
DAP5 antibody [C2C3], C-term

Purification: Purified by antigen-affinity chromatography.

Immunogène: Recombinant protein encompassing a sequence within the C-terminus region of human DAP5. The exact sequence is proprietary.

Isotype: IgG

Information d'application

Indications d'application: WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

Commentaires:

Positive Control: Mouse brain , HeLa , HepG2

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.39 mg/mL

Buffer: 0.1M Tris-Glycine ( pH 7), 10 % Glycerol, 0.01 % Thimerosal

Agent conservateur: Thimerosal (Merthiolate)

Précaution d'utilisation: This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Détails sur EIF4G2

Antigène: EIF4G2 (Eukaryotic Translation Initiation Factor 4 gamma 2 (EIF4G2))

Autre désignation: eukaryotic translation initiation factor 4 gamma 2 (EIF4G2 Produits)

Synonymes: anticorps AAG1, anticorps DAP5, anticorps NAT1, anticorps P97, anticorps NAT1B, anticorps eif4g2, anticorps hm:zeh1307, anticorps wu:fa14h01, anticorps wu:fb44h01, anticorps wu:fb59c06, anticorps wu:fc21b05, anticorps EIF4G2, anticorps AA589388, anticorps DAP-5, anticorps E130105L11Rik, anticorps Nat1, anticorps Natm1, anticorps p97, anticorps NAT1A, anticorps im:7148615, anticorps wu:fb81f07, anticorps wu:fb82b06, anticorps wu:fb98h08, anticorps dap5, anticorps eif4g2.L, anticorps nat1, anticorps eukaryotic translation initiation factor 4 gamma 2, anticorps eukaryotic translation initiation factor 4, gamma 2b, anticorps eukaryotic translation initiation factor 4, gamma 2, anticorps eukaryotic translation initiation factor 4 gamma, 2, anticorps eIF4G-related protein NAT1, anticorps eukaryotic translation initiation factor 4, gamma 2a, anticorps eukaryotic translation initiation factor 4 gamma, 2 S homeolog, anticorps EIF4G2, anticorps eif4g2b, anticorps Eif4g2, anticorps nat1, anticorps eif4g2a, anticorps eif4g2.S

Sujet: Translation initiation is mediated by specific recognition of the cap structure by eukaryotic translation initiation factor 4F (eIF4F), which is a cap binding protein complex that consists of three subunits: eIF4A, eIF4E and eIF4G. The protein encoded by this gene shares similarity with the C-terminal region of eIF4G that contains the binding sites for eIF4A and eIF3, eIF4G, in addition, contains a binding site for eIF4E at the N-terminus. Unlike eIF4G, which supports cap-dependent and independent translation, this gene product functions as a general repressor of translation by forming translationally inactive complexes. In vitro and in vivo studies indicate that translation of this mRNA initiates exclusively at a non-AUG (GUG) codon. Alternatively spliced transcript variants encoding different isoforms of this gene have been described.

Poids moléculaire: 102 kDa

ID gène: 1982

UniProt: P78344